277 related articles for article (PubMed ID: 23222736)
1. Cytotoxic effector function of CD4-independent, CD8(+) T cells is mediated by TNF-α/TNFR.
Zimmerer JM; Horne PH; Fiessinger LA; Fisher MG; Pham TA; Saklayen SL; Bumgardner GL
Transplantation; 2012 Dec; 94(11):1103-10. PubMed ID: 23222736
[TBL] [Abstract][Full Text] [Related]
2. Disparate primary and secondary allospecific CD8+ T cell cytolytic effector function in the presence or absence of host CD4+ T cells.
Horne PH; Koester MA; Jayashankar K; Lunsford KE; Dziema HL; Bumgardner GL
J Immunol; 2007 Jul; 179(1):80-8. PubMed ID: 17579024
[TBL] [Abstract][Full Text] [Related]
3. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
[TBL] [Abstract][Full Text] [Related]
4. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
Kafrouni MI; Brown GR; Thiele DL
J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
Horne PH; Lunsford KE; Eiring AM; Wang Y; Gao D; Bumgardner GL
Transplantation; 2005 Aug; 80(4):514-21. PubMed ID: 16123727
[TBL] [Abstract][Full Text] [Related]
6. Unique CD8+ T Cell-Mediated Immune Responses Primed in the Liver.
Zimmerer JM; Horne PH; Fisher MG; Pham TA; Lunsford KE; Ringwald BA; Avila CL; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1907-15. PubMed ID: 27379551
[TBL] [Abstract][Full Text] [Related]
7. Invariant NKT Cells Promote the Development of Highly Cytotoxic Multipotent CXCR3
Zimmerer JM; Ringwald BA; Chaudhari SR; Han J; Peterson CM; Warren RT; Hart MM; Abdel-Rasoul M; Bumgardner GL
J Immunol; 2021 Dec; 207(12):3107-3121. PubMed ID: 34810223
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.
Zimmerer JM; Horne PH; Fiessinger LA; Fisher MG; Jayashankar K; Garcia SF; Abdel-Rasoul M; van Rooijen N; Bumgardner GL
Cell Transplant; 2013; 22(7):1157-69. PubMed ID: 23069206
[TBL] [Abstract][Full Text] [Related]
9. Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.
Horne PH; Zimmerer JM; Fisher MG; Lunsford KE; Nadasdy G; Nadasdy T; van Rooijen N; Bumgardner GL
J Immunol; 2008 Jul; 181(2):1224-31. PubMed ID: 18606676
[TBL] [Abstract][Full Text] [Related]
10. T-cell subsets mediate graft-versus-myeloid leukemia responses via different cytotoxic mechanisms.
Hsieh MH; Patterson AE; Korngold R
Biol Blood Marrow Transplant; 2000; 6(3):231-40. PubMed ID: 10871148
[TBL] [Abstract][Full Text] [Related]
11. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
Suresh M; Gao X; Fischer C; Miller NE; Tewari K
J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
[TBL] [Abstract][Full Text] [Related]
12. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
Teh HS; Seebaran A; Teh SJ
J Immunol; 2000 Nov; 165(9):4814-21. PubMed ID: 11046004
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic pathways in the skin allograft rejection by CD4+ T cells.
Ito A; Minagawa M; Tomiyama K; Ito M; Kawai K
Transplantation; 1999 Jul; 68(1):97-100. PubMed ID: 10428275
[TBL] [Abstract][Full Text] [Related]
14. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.
Bumgardner GL; Gao D; Li J; Baskin JH; Heininger M; Orosz CG
Transplantation; 2000 Dec; 70(12):1771-80. PubMed ID: 11152110
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cells.
Varanasi V; Avanesyan L; Schumann DM; Chervonsky AV
Diabetes; 2012 Nov; 61(11):2862-70. PubMed ID: 22773667
[TBL] [Abstract][Full Text] [Related]
16. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
[TBL] [Abstract][Full Text] [Related]
17. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
18. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
[TBL] [Abstract][Full Text] [Related]
19. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
Zhan Y; Brady JL; Sutherland RM; Lew AM
J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
[TBL] [Abstract][Full Text] [Related]
20. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
